This PDF is the current document as it appeared on Public Inspection on 05/24/2017 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.Start Printed Page 24131
|Title of collection||OMB control No.||Date approval expires|
|Procedures for the Safe Processing and Importing of Fish and Fishery Products||0910-0354||2/29/2020|
|Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations; Form FDA 3486 and Addendum, 3486A||0910-0458||2/29/2020|
|Designation of New Animal Drugs for Minor Use or Minor Species||0910-0605||2/29/2020|
|Unique Device Identification System||0910-0720||2/29/2020|
|Animal Feed Regulatory Program Standards||0910-0760||2/29/2020|
|Premarket Approval of Medical Devices—21 CFR Part 814||0910-0231||3/31/2020|
|Human Tissue Intended for Transplantation||0910-0302||3/31/2020|
|General Licensing Provisions: Biological License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Form FDA 356h||0910-0338||3/31/2020|
Dated: May 18, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislative, and Analysis.
[FR Doc. 2017-10736 Filed 5-24-17; 8:45 am]
BILLING CODE 4164-01-P